Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine for Cardiac Ischemia in CABG
NCT01002859Phase 2Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- Apr 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ciclosporin in myocardial ischemia-reperfusion injury, sponsored by CHU Grenoble Alpes. Started Apr 2009; status: terminated.
02
Drugs
ciclosporin
03
Conditions
myocardial ischemia-reperfusion injury
Beyond the preview
Go deeper on NCT01002859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002859.